Colombel et al. (4) reported that frequent monitoring of plasma C-reactive protein (CRP) and fecal calprotectin, alongside the Crohn's Disease Activity Index (CDAI), was associated with higher rates of mucosal healing because of earlier and more intensive clinical management compared with using CDAI alone. This evidence concerns the gene CRP and Crohn disease.